Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07383740 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment openedv3 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Sep 2027 to Sep 1, 2027
    • Study completion date: Oct 2027 to Oct 1, 2027
    • Start date changed from estimate of Mar 2026 to Apr 21, 2026
  2. Eligibility criteria revisedv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA). Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. After screening for contraindications, participants will perform the aEB-test twice within 1-2 weeks. The investigators hypothezise that the test will demonstrate acceptable test-retest reliability in patients with hip- and/or knee OA. To establish reliability is essential for future studies using this test in this population and may support its integration into routine clinical assessment.
Trial Details
NCT Number NCT07383740
Lead Sponsor Vastra Gotaland Region
Conditions
(from sponsor)		 Osteo Arthritis Knee and Hip
Related terms Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov